Sign In
Buy COR
$263.64
-1.20 (-0.453%)
At Close: Jun 03, 2026
Cencora Inc (COR) Q1 2026 Earnings Call Highlights: Strong US Growth Amid International Challenges
04:05pm, Wednesday, 04'th Feb 2026
Adjusted Diluted EPS: $4.08, an increase of 9%.Consolidated Revenue: $85.9 billion, up 5.5%.Consolidated Gross Profit: $3.0 billion, up 18%.Gross Profit Margin
Cencora, Inc. (COR) Q1 2026 Earnings Call Transcript
01:10pm, Wednesday, 04'th Feb 2026
Cencora, Inc. (COR) Q1 2026 Earnings Call Transcript
Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves
01:01pm, Wednesday, 04'th Feb 2026
COR shares slip despite Q1 EPS beat and revenues match estimates, margins expand and fiscal 2026 growth guidance up.
Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss
11:32am, Wednesday, 04'th Feb 2026
Cencora reported higher Q1 earnings but missed revenue estimates, driven by U.S. and European drug sales growth.
Cencora (COR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
10:31am, Wednesday, 04'th Feb 2026
The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Cencora (COR) Q1 Earnings Top Estimates
08:41am, Wednesday, 04'th Feb 2026
Cencora (COR) came out with quarterly earnings of $4.08 per share, beating the Zacks Consensus Estimate of $4.07 per share. This compares to earnings of $3.73 per share a year ago.
Cencora beats quarterly profit estimates on strong demand for specialty medicines
08:20am, Wednesday, 04'th Feb 2026
Cencora on Wednesday beat Wall Street estimates for first-quarter profit, as the drug distributor rode the wave of sustained demand for specialty medicines and GLP-1 therapies.
Cencora Reports Fiscal 2026 First Quarter Results
06:30am, Wednesday, 04'th Feb 2026
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2026 first quarter ended December 31, 2025, revenue increased 5.5 percent year-over-year to $85.9 billion
Mawer Investment Management Ltd. Reduces Stock Holdings in Cencora, Inc. $COR
05:56am, Monday, 02'nd Feb 2026
Mawer Investment Management Ltd. lessened its position in Cencora, Inc. (NYSE: COR) by 3.1% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commissio
Mediolanum International Funds Ltd Purchases 32,138 Shares of Cencora, Inc. $COR
05:56am, Monday, 02'nd Feb 2026
Mediolanum International Funds Ltd lifted its position in Cencora, Inc. (NYSE: COR) by 133.0% in the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor
Thrivent Financial for Lutherans Cuts Holdings in Cencora, Inc. $COR
05:56am, Monday, 02'nd Feb 2026
Thrivent Financial for Lutherans lowered its holdings in Cencora, Inc. (NYSE: COR) by 3.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 245
Strategy Asset Managers LLC Acquires 2,183 Shares of Cencora, Inc. $COR
05:15am, Monday, 02'nd Feb 2026
Strategy Asset Managers LLC lifted its stake in Cencora, Inc. (NYSE: COR) by 133.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchan
Exploring Analyst Estimates for Cencora (COR) Q1 Earnings, Beyond Revenue and EPS
10:15am, Friday, 30'th Jan 2026
Besides Wall Street's top-and-bottom-line estimates for Cencora (COR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar
Bank of New York Mellon Corp Increases Stake in Cencora, Inc. $COR
04:18am, Friday, 30'th Jan 2026
Bank of New York Mellon Corp lifted its stake in Cencora, Inc. (NYSE: COR) by 1.5% during the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor owned
Can Specialty and International Momentum Support Cencora's Q1 Results?
09:36am, Thursday, 29'th Jan 2026
COR's Q1 outlook is supported by specialty utilization, RCA momentum, and steady international growth, even as GLP-1 tailwinds ease.
